Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1^−/− mice

References

• Zhang N, Alicot EM, Chiu I, Li J, Verna N, Vorup-Jensen T, et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 2006; 203: 141–152
   PubMed Web of Science ®Google Scholar
• Fleming SD, Monestier M, Tsokos GC. Accelerated ischemia/reperfusion-induced injury in autoimmunity prone mice. J Immunol 2004; 173: 4230–4235
   PubMedGoogle Scholar
• Fleming SD, Egan RP, Chai C, Girardi, Holers VM, Salmon J, et al. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol 2004; 173: 7055–7061
   PubMedGoogle Scholar
• Greidinger EL, Hoffman RW. Autoantibodies in the pathogenesis of mixed connective tissue disease. Rheum Dis Clin N Am 2005; 31: 437–450
   PubMedGoogle Scholar
• Aringer M, Steiner G, Smolen JS. Does mixed connective tissue disease exist? Yes. Rheum Dis Clin N Am 2005; 31: 411–420
   PubMed Web of Science ®Google Scholar
• Greidinger EL, Hoffman RW. The appearance of U1-RNP antibody specificites in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B′/B proteins as predominant U1-RNP immunogens. Arthritis Rheum 2001; 44: 368–375
   PubMed Web of Science ®Google Scholar
• Jindal SK, Agarwal R. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med 2005; 11: 438–446
   PubMed Web of Science ®Google Scholar
• Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003; 22: 358–363
   PubMed Web of Science ®Google Scholar
• Nishimaki T, Aotsuka S, Kondo H, Yamamoto K, Takasaki Y, Sumiya M, Yokohari R. Immunological analysis of pulmonary hypertension in connective tissue diseases. J Rheumatol 1999; 26: 2357–2362
   PubMed Web of Science ®Google Scholar
• Greidinger EL, Casciola-Rosen L, Morris SM, Hoffman RW, Rosen A. Autoantibody recognition of distinctly modified forms of the U1-70 kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 2000; 43: 881–888
   PubMedGoogle Scholar
• Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Sumiya M, Yokohari R. Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: Implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD). Clin Exp Immunol 1994; 98: 427–433
   PubMed Web of Science ®Google Scholar
• Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol 1999; 116: 174–180
   PubMedGoogle Scholar
• Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Takaono M, Iwasaki K, Kinoshita M, Sumiya M. Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases. Clin Exp Immunol 2001; 126: 345–354
   PubMedGoogle Scholar
• Greidinger EL, Zang YJ, Jaimes K, Hogenmiller S, Nassiri, Bejarano P, et al. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 2006; 54: 661–669
   PubMed Web of Science ®Google Scholar
• Fleming SD, Mastellos D, Karpel-Massler G, Shea-Donohue T, Lambirs JD, Tsokos GC. C5a caused limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. Clin Immunol 2003; 108: 263–273
   PubMed Web of Science ®Google Scholar
• Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Crawforf JM, Ferrara JLM. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I The roles of minor H antigens and endotoxin. Blood 1996; 8: 3230–3239
   Google Scholar
• Williams JP, Pechet TTV, Weiser MR, Reid R, Kobzik L, Moore FD, et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 1999; 86: 938–942
   PubMed Web of Science ®Google Scholar
• Fleming SD, Tsokos GC. Complement, natural antibodies, autoantibodies and tissue injury. Autoinnum Rev 2006; 5: 89–92
   PubMed Web of Science ®Google Scholar
• Fleming SD, Anderson J, Wilson F, She-Donohue T, Tsokos GC. C5 is required for CD49 expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion. Clin Immunol 2003; 106: 55–64
   PubMedGoogle Scholar
• Stein CM, Tanner SB, Awad JS, Roberts LJ, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 1996; 39: 1146–1150
   PubMed Web of Science ®Google Scholar
• Zhang M, Austen WG, Chiu I, Alicot EM, Humg R, Ma M, Verna N, Xu M, Hechtman HB, Moore FD, Carroll MC. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 2004; 101: 3886–3891
   PubMed Web of Science ®Google Scholar